Amin, M. N., J. S. McLellan, W. Huang, J. Orwenyo, D. R. Burton, W. C. Koff, P. D. Kwong and L. X. Wang (2013). "Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies." Nat Chem Biol 9(8): 521-526.



Amornkul, P. N., E. Karita, A. Kamali, W. N. Rida, E. J. Sanders, S. Lakhi, M. A. Price, W. Kilembe, E. Cormier, O. Anzala, M. H. Latka, L. G. Bekker, S. A. Allen, J. Gilmour, P. E. Fast and I. A. H. P. Partnership (2013). "Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa." AIDS 27(17): 2775-2786.



Asiki, G., A. Abaasa, E. Ruzagira, F. Kibengo, U. Bahemuka, J. Mulondo, J. Seeley, L. G. Bekker, S. Delany, P. Kaleebu and A. Kamali (2013). Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda." Vaccine 31(44): 5055-5061.



Baalwa, J., S. Wang, N. F. Parrish, J. M. Decker, B. F. Keele, G. H. Learn, L. Yue, E. Ruzagira, D. Ssemwanga, A. Kamali, P. N. Amornkul, M. A. Price, J. C. Kappes, E. Karita, P. Kaleebu, E. Sanders, J. Gilmour, S. Allen, E. Hunter, D. C. Montefiori, B. F. Haynes, E. Cormier, B. H. Hahn and G. M. Shaw (2013). "Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones." Virology 436(1): 33-48              



Bhattacharyya, S., P. Singh, U. Rathore, M. Purwar, D. Wagner, H. Arendt, J. DeStefano, C. C. LaBranche, D. C. Montefiori, S. Phogat and R. Varadarajan (2013). "Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodies." J Biol Chem 288(14): 9815-9825.         



Camlin, C., Z. Kwena and S. Dworkin (2013). "Jaboya vs. jakambi: Status, negotiation, and HIV risks among female migrants in the "sex for fish" economy in Nyanza Province, Kenya." AIDS Educ Prev 25: 216 - 231.



Chakrabarti, B. K., Y. Feng, S. K. Sharma, K. McKee, G. B. Karlsson Hedestam, C. C. Labranche, D. C. Montefiori, J. R. Mascola and R. T. Wyatt (2013). "Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates." J Virol 87(24): 13239-13251.



Chersich, M., S. Luchters, I. Ntaganira, A. Gerbase, Y. Lo, F. Scorgie and R. Steen (2013). "Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services." J Int AIDS Soc 16: 17980.             



Crispin, M. and T. A. Bowden (2013). "Antibodies expose multiple weaknesses in the glycan shield of HIV." Nat Struct Mol Biol 20(7): 771-772.



Demidenko, A. A., J. N. Blattman, N. N. Blattman, P. D. Greenberg and M. L. Nibert (2013). "Engineering recombinant reoviruses with tandem repeats and a tetravirus 2A-like element for exogenous polypeptide expression." Proc Natl Acad Sci U S A 110(20): E1867-1876.             



Dionne-Odom, J., E. Karita, W. Kilembe, F. Henderson, B. Vwalika, R. Bayingana, Z. Li, J. Mulenga, E. Chomba, C. Del Rio, N. H. Khu, A. Tichacek and S. Allen (2013). "Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda." Clin Infect Dis 56(12): 1829-1837.



Doores, K. J., M. Huber, K. M. Le, S. K. Wang, C. Doyle-Cooper, A. Cooper, R. Pantophlet, C. H. Wong, D. Nemazee and D. R. Burton (2013). "2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies." J Virol 87(4): 2234-2241.               



Doyle-Cooper, C., K. E. Hudson, A. B. Cooper, T. Ota, P. Skog, P. E. Dawson, M. B. Zwick, W. R. Schief, D. R. Burton and D. Nemazee (2013). "Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10." J Immunol 191(6): 3186-3191.       




El-Sadr, W., D. Serwadda, N. Sista and M. Cohen (2013). "HIV prevention: great achievements, more challenges ahead." J Acquir Immune Defic Syndr 63(Suppl 2): S115 - S116.               



Etcheverry, M., J. Evans, E. Sanchez, E. Mendez-Arancibia, M. Merono, J. Gatell, K. Page and J. Joseph (2013). "Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials." Hum Vaccin Immunother 9: 420 - 429.              



Fast, P. E., M. A. Price, W. N. Rida, A. Kamali, E. Karita and A. V. I. A. E. I. R. G. International (2013). "WHO's new guidelines for antiretroviral treatment." Lancet 382(9907): 1778-1779.               



Feng, Y., M. N. Forsell, B. Flynn, W. Adams, K. Lore, R. Seder, R. T. Wyatt and G. B. Karlsson Hedestam (2013). "Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants." Virology 446(1-2): 56-65.              



Forsell, M. N., M. Soldemo, P. Dosenovic, R. T. Wyatt, M. C. Karlsson and G. B. Karlsson Hedestam (2013). "Independent expansion of epitope-specific plasma cell responses upon HIV-1 envelope glycoprotein immunization." J Immunol 191(1): 44-51.              



Gach, J. S., H. Quendler, T. Tong, K. M. Narayan, S. X. Du, R. G. Whalen, J. M. Binley, D. N. Forthal, P. Poignard and M. B. Zwick (2013). "A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1." PLoS One 8(8): e72054.        



Georgiev, I. S., N. A. Doria-Rose, T. Zhou, Y. D. Kwon, R. P. Staupe, S. Moquin, G. Y. Chuang, M. K. Louder, S. D. Schmidt, H. R. Altae-Tran, R. T. Bailer, K. McKee, M. Nason, S. O'Dell, G. Ofek, M. Pancera, S. Srivatsan, L. Shapiro, M. Connors, S. A. Migueles, L. Morris, Y. Nishimura, M. A. Martin, J. R. Mascola and P. D. Kwong (2013). "Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization." Science 340(6133): 751-756.               




Graham, S. M., P. Mugo, E. Gichuru, A. Thiong'o, M. Macharia, H. S. Okuku, E. van der Elst, M. A. Price, N. Muraguri and E. J. Sanders (2013). "Adherence to antiretroviral therapy and clinical outcomes among young adults reporting high-risk sexual behavior, including men who have sex with men, in coastal Kenya." AIDS Behav 17(4): 1255-1265.            



Hammer, S., M. Sobieszczyk, H. Janes, S. Karuna, M. Mulligan, D. Grove, B. Koblin, S. Buchbinder, M. Keefer, G. Tomaras, N. Frahm, J. Hural, C. Anude, B. Graham, M. Enama, E. Adams, E. DeJesus, R. Novak, I. Frank, C. Bentley, S. Ramirez, R. Fu, R. Koup, J. Mascola, G. Nabel, D. Montefiori, J. Kublin, M. McElrath, L. Corey and P. Gilbert (2013). "Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine." N Engl J Med 369: 2083 - 2092.             



Hansen, S. G., M. Piatak, Jr., A. B. Ventura, C. M. Hughes, R. M. Gilbride, J. C. Ford, K. Oswald, R. Shoemaker, Y. Li, M. S. Lewis, A. N. Gilliam, G. Xu, N. Whizin, B. J. Burwitz, S. L. Planer, J. M. Turner, A. W. Legasse, M. K. Axthelm, J. A. Nelson, K. Fruh, J. B. Sacha, J. D. Estes, B. F. Keele, P. T. Edlefsen, J. D. Lifson and L. J. Picker (2013). "Immune clearance of highly pathogenic SIV infection." Nature 502(7469): 100-104.             



Hansen, S. G., J. B. Sacha, C. M. Hughes, J. C. Ford, B. J. Burwitz, I. Scholz, R. M. Gilbride, M. S. Lewis, A. N. Gilliam, A. B. Ventura, D. Malouli, G. Xu, R. Richards, N. Whizin, J. S. Reed, K. B. Hammond, M. Fischer, J. M. Turner, A. W. Legasse, M. K. Axthelm, P. T. Edlefsen, J. A. Nelson, J. D. Lifson, K. Fruh and L. J. Picker (2013). "Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms." Science 340(6135): 1237874.            



Hassan, A. S., S. M. Mwaringa, C. A. Obonyo, H. M. Nabwera, E. J. Sanders, T. F. Rinke de Wit, P. A. Cane and J. A. Berkley (2013). "Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya." AIDS Res Hum Retroviruses 29(1): 129-135.               



Hayes, P., J. Gilmour, A. von Lieven, D. Gill, L. Clark, J. Kopycinski, H. Cheeseman, A. Chung, G. Alter, L. Dally, D. Zachariah, A. Lombardo, J. Ackland, E. Sayeed, A. Jackson, M. Boffito, B. Gazzard, P. E. Fast, J. H. Cox and D. Laufer (2013). "Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults." Clin Vaccine Immunol 20(3): 397-408.      



Hoffenberg, S., R. Powell, A. Carpov, D. Wagner, A. Wilson, S. Kosakovsky Pond, R. Lindsay, H. Arendt, J. Destefano, S. Phogat, P. Poignard, S. P. Fling, M. Simek, C. Labranche, D. Montefiori, T. Wrin, P. Phung, D. Burton, W. Koff, C. R. King, C. L. Parks and M. J. Caulfield (2013). "Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes." J Virol 87(10): 5372-5383.              



Jardine, J., J. P. Julien, S. Menis, T. Ota, O. Kalyuzhniy, A. McGuire, D. Sok, P. S. Huang, S. MacPherson, M. Jones, T. Nieusma, J. Mathison, D. Baker, A. B. Ward, D. R. Burton, L. Stamatatos, D. Nemazee, I. A. Wilson and W. R. Schief (2013). "Rational HIV immunogen design to target specific germline B cell receptors." Science 340(6133): 711-716.              



Julien, J. P., A. Cupo, D. Sok, R. L. Stanfield, D. Lyumkis, M. C. Deller, P. J. Klasse, D. R. Burton, R. W. Sanders, J. P. Moore, A. B. Ward and I. A. Wilson (2013). "Crystal structure of a soluble cleaved HIV-1 envelope trimer." Science 342(6165): 1477-1483.             



Julien, J. P., J. H. Lee, A. Cupo, C. D. Murin, R. Derking, S. Hoffenberg, M. J. Caulfield, C. R. King, A. J. Marozsan, P. J. Klasse, R. W. Sanders, J. P. Moore, I. A. Wilson and A. B. Ward (2013). "Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9." Proc Natl Acad Sci U S A 110(11): 4351-4356.             




Khayat, R., J. H. Lee, J. P. Julien, A. Cupo, P. J. Klasse, R. W. Sanders, J. P. Moore, I. A. Wilson and A. B. Ward (2013). "Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers." J Virol 87(17): 9865-9872.              



Khu, N. H., B. Vwalika, E. Karita, W. Kilembe, R. A. Bayingana, D. Sitrin, H. Roeber-Rice, E. Learner, A. C. Tichacek, L. B. Haddad, K. M. Wall, E. N. Chomba and S. A. Allen (2013). "Fertility goal-based counseling increases contraceptive implant and IUD use in HIV-discordant couples in Rwanda and Zambia." Contraception 88(1): 74-82.             



Kibengo, F. M., E. Ruzagira, D. Katende, A. N. Bwanika, U. Bahemuka, J. E. Haberer, D. R. Bangsberg, B. Barin, J. F. Rooney, D. Mark, P. Chetty, P. Fast, A. Kamali and F. H. Priddy (2013). "Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial." PLoS One 8(9): e74314.                             



Kiwanuka, N., A. Ssetaala, J. Mpendo, M. Wambuzi, A. Nanvubya, S. Sigirenda, A. Nalutaaya, P. Kato, L. Nielsen, P. Kaleebu, J. Nalusiba and N. K. Sewankambo (2013). "High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda." J Int AIDS Soc 16(1): 18621.        



Klasse, P. J., R. S. Depetris, R. Pejchal, J. P. Julien, R. Khayat, J. H. Lee, A. J. Marozsan, A. Cupo, N. Cocco, J. Korzun, A. Yasmeen, A. B. Ward, I. A. Wilson, R. W. Sanders and J. P. Moore (2013). "Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein." J Virol 87(17): 9873-9885.



Koff, W. C., D. R. Burton, P. R. Johnson, B. D. Walker, C. R. King, G. J. Nabel, R. Ahmed, M. K. Bhan and S. A. Plotkin (2013). "Accelerating next-generation vaccine development for global disease prevention." Science 340(6136): 1232910.               



Koff, W. C., N. D. Russell, M. Walport, M. B. Feinberg, J. W. Shiver, S. A. Karim, B. D. Walker, M. G. McGlynn, C. V. Nweneka and G. J. Nabel (2013). "Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines." Vaccine 31 Suppl 2(0): B204-208.            



Kong, L., J. H. Lee, K. J. Doores, C. D. Murin, J. P. Julien, R. McBride, Y. Liu, A. Marozsan, A. Cupo, P. J. Klasse, S. Hoffenberg, M. Caulfield, C. R. King, Y. Hua, K. M. Le, R. Khayat, M. C. Deller, T. Clayton, H. Tien, T. Feizi, R. W. Sanders, J. C. Paulson, J. P. Moore, R. L. Stanfield, D. R. Burton, A. B. Ward and I. A. Wilson (2013). "Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120." Nat Struct Mol Biol 20(7): 796-803.             



Kwena, Z., C. Camlin, C. Shisanya, I. Mwanzo and E. Bukusi (2013). "Short-term mobility and the risk of HIV infection among married couples in the fishing communities along Lake Victoria, Kenya." PLoS One 8: e54523.               



Lindsay, R. W., I. Ouellette, H. E. Arendt, J. Martinez, J. DeStefano, M. Lopez, G. N. Pavlakis, M. J. Chiuchiolo, C. L. Parks and C. R. King (2013). "SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12." Vaccine 31(42): 4749-4758.              



Locci, M., C. Havenar-Daughton, E. Landais, J. Wu, M. A. Kroenke, C. L. Arlehamn, L. F. Su, R. Cubas, M. M. Davis, A. Sette, E. K. Haddad, A. V. I. P. C. P. I. International, P. Poignard and S. Crotty (2013). "Human circulating PD-(+)1CXCR3(-)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses." Immunity 39(4): 758-769.               



Lyumkis, D., J. P. Julien, N. de Val, A. Cupo, C. S. Potter, P. J. Klasse, D. R. Burton, R. W. Sanders, J. P. Moore, B. Carragher, I. A. Wilson and A. B. Ward (2013). "Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer." Science 342(6165): 1484-1490.                .



Mao, Y., L. Wang, C. Gu, A. Herschhorn, A. Desormeaux, A. Finzi, S. H. Xiang and J. G. Sodroski (2013). "Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer." Proc Natl Acad Sci U S A 110(30): 12438-12443.               



Martins, M. A., M. C. Bonaldo, R. A. Rudersdorf, S. M. Piaskowski, E. G. Rakasz, K. L. Weisgrau, J. R. Furlott, C. M. Eernisse, M. G. Veloso de Santana, B. Hidalgo, T. C. Friedrich, M. J. Chiuchiolo, C. L. Parks, N. A. Wilson, D. B. Allison, R. Galler and D. I. Watkins (2013). "Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques." PLoS One 8(1): e54434.                .



McGuire, A. T., S. Hoot, A. M. Dreyer, A. Lippy, A. Stuart, K. W. Cohen, J. Jardine, S. Menis, J. F. Scheid, A. P. West, W. R. Schief and L. Stamatatos (2013). "Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies." J Exp Med 210(4): 655-663.     



Mehendale, S., M. Thakar, S. Sahay, M. Kumar, A. Shete, P. Sathyamurthi, A. Verma, S. Kurle, A. Shrotri, J. Gilmour, R. Goyal, L. Dally, E. Sayeed, D. Zachariah, J. Ackland, S. Kochhar, J. H. Cox, J. L. Excler, V. Kumaraswami, R. Paranjape and V. D. Ramanathan (2013). "Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers." PLoS One 8(2): e55831.              



Mugo, P. M., S. Duncan, S. W. Mwaniki, A. N. Thiong'o, E. Gichuru, H. S. Okuku, E. M. van der Elst, A. D. Smith, S. M. Graham and E. J. Sanders (2013). "Cross-sectional survey of treatment practices for urethritis at pharmacies, private clinics and government health facilities in coastal Kenya: many missed opportunities for HIV prevention." Sex Transm Infect 89(7): 583-589.           



Murphy, M. K., L. Yue, R. Pan, S. Boliar, A. Sethi, J. Tian, K. Pfafferot, E. Karita, S. A. Allen, E. Cormier, P. A. Goepfert, P. Borrow, J. E. Robinson, S. Gnanakaran, E. Hunter, X. P. Kong and C. A. Derdeyn (2013). "Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth." PLoS Pathog 9(2): e1003173.              




Nazziwa, J., H. F. Njai, N. Ndembi, J. Birungi, F. Lyagoba, A. Gershim, J. Nakiyingi-Miiro, L. Nielsen, J. Mpendo, A. Nanvubya, J. Debont, H. Grosskurth, A. Kamali, J. Seeley, P. Kaleebu and T. Chivtum Study (2013). "Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria." AIDS Res Hum Retroviruses 29(5): 788-795.              



Ota, T., C. Doyle-Cooper, A. B. Cooper, K. J. Doores, M. Aoki-Ota, K. Le, W. R. Schief, R. T. Wyatt, D. R. Burton and D. Nemazee (2013). "B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates." J Immunol 191(6): 3179-3185.              




Pancera, M., S. Shahzad-Ul-Hussan, N. A. Doria-Rose, J. S. McLellan, R. T. Bailer, K. Dai, S. Loesgen, M. K. Louder, R. P. Staupe, Y. Yang, B. Zhang, R. Parks, J. Eudailey, K. E. Lloyd, J. Blinn, S. M. Alam, B. F. Haynes, M. N. Amin, L. X. Wang, D. R. Burton, W. C. Koff, G. J. Nabel, J. R. Mascola, C. A. Bewley and P. D. Kwong (2013). "Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16." Nat Struct Mol Biol 20(7): 804-813.              



Pancera, M., Y. Yang, M. K. Louder, J. Gorman, G. Lu, J. S. McLellan, J. Stuckey, J. Zhu, D. R. Burton, W. C. Koff, J. R. Mascola and P. D. Kwong (2013). "N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function." PLoS One 8(2): e55701.           




Parks, C. L., L. J. Picker and C. R. King (2013). "Development of replication-competent viral vectors for HIV vaccine delivery." Curr Opin HIV AIDS 8(5): 402-411.    



Powell, R. L., R. W. Lindsay, A. Wilson, A. Carpov, S. Rabinovich, S. Hoffenberg and M. J. Caulfield (2013). "Rapid, quantitative mapping of anti-HIV type 1 envelope serum antibody specificities." AIDS Res Hum Retroviruses 29(6): 971-978.              



Powell, R. L., I. Ouellette, R. W. Lindsay, C. L. Parks, C. R. King, A. B. McDermott and G. Morrow (2013). "A Multiplex Microsphere-Based Immunoassay Increases the Sensitivity of SIV-Specific Antibody Detection in Serum Samples and Mucosal Specimens Collected from Rhesus Macaques Infected with SIVmac239." Biores Open Access 2(3): 171-178.   



Prentice, H. A., T. R. Porter, M. A. Price, E. Cormier, D. He, P. K. Farmer, A. Kamali, E. Karita, S. Lakhi, E. J. Sanders, O. Anzala, P. N. Amornkul, S. Allen, E. Hunter, R. A. Kaslow, J. Gilmour, J. Tang and I. A. H. R. Network (2013). "HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race?" J Virol 87(7): 4043-4051.              



Ringe, R. and J. Bhattacharya (2013). "Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1)." Ther Adv Vaccines 1(2): 67-80.     



Rubens, D. (2013). "Science writing workshops for AIDS vaccine researchers in Africa." Medical Writing 22(2): 108-111.



Sanders, E. J., H. S. Okuku, A. D. Smith, M. Mwangome, E. Wahome, G. Fegan, N. Peshu, E. M. van der Elst, M. A. Price, R. S. McClelland and S. M. Graham (2013). "High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among MSM." AIDS 27(3): 437-446.              



Sanders, R. W., R. Derking, A. Cupo, J. P. Julien, A. Yasmeen, N. de Val, H. J. Kim, C. Blattner, A. T. de la Pena, J. Korzun, M. Golabek, K. de Los Reyes, T. J. Ketas, M. J. van Gils, C. R. King, I. A. Wilson, A. B. Ward, P. J. Klasse and J. P. Moore (2013). "A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies." PLoS Pathog 9(9): e1003618.              



Schief, W. (2013). "Computation-Guided Vaccine Design." Biophysical Journal 104(2): 185a.       



Schiffner, T., L. Kong, C. J. Duncan, J. W. Back, J. J. Benschop, X. Shen, P. S. Huang, G. B. Stewart-Jones, J. DeStefano, M. S. Seaman, G. D. Tomaras, D. C. Montefiori, W. R. Schief and Q. J. Sattentau (2013). "Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking." J Virol 87(18): 10163-10172.     



Schmidt, C., W. Jaoko, G. Omosa-Manyonyi, P. Kaleebu, J. Mpendo, A. Nanvubya, E. Karita, R. Bayingana, L. G. Bekker, E. Chomba, W. Kilembe, M. Nchabeleng, J. Nyombayire, G. Stevens, P. Chetty, J. Lehrman, J. Cox, S. Allen, L. Dally, C. Smith and P. E. Fast (2013). "Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa." Hum Vaccin Immunother 10(3).              



Sok, D., U. Laserson, J. Laserson, Y. Liu, F. Vigneault, J. P. Julien, B. Briney, A. Ramos, K. F. Saye, K. Le, A. Mahan, S. Wang, M. Kardar, G. Yaari, L. M. Walker, B. B. Simen, E. P. St John, P. Y. Chan-Hui, K. Swiderek, S. H. Kleinstein, G. Alter, M. S. Seaman, A. K. Chakraborty, D. Koller, I. A. Wilson, G. M. Church, D. R. Burton and P. Poignard (2013). "The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies." PLoS Pathog 9(11): e1003754.              



Sundling, C., P. Martinez, M. Soldemo, M. Spangberg, K. L. Bengtsson, L. Stertman, M. N. Forsell and G. B. Karlsson Hedestam (2013). "Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting." J Infect Dis 207(3): 426-431.     



Taegtmeyer, M., A. Davies, M. Mwangome, E. M. van der Elst, S. M. Graham, M. A. Price and E. J. Sanders (2013). "Challenges in providing counselling to MSM in highly stigmatized contexts: results of a qualitative study from Kenya." PLoS One 8(6): e64527.            



van der Elst, E. M., E. Gichuru, A. Omar, J. Kanungi, Z. Duby, M. Midoun, S. Shangani, S. M. Graham, A. D. Smith, E. J. Sanders and D. Operario (2013). "Experiences of Kenyan healthcare workers providing services to men who have sex with men: qualitative findings from a sensitivity training programme." J Int AIDS Soc 16 Suppl 3(4 Suppl 3): 18741.           



Van der Elst, E. M., J. Mbogua, D. Operario, G. Mutua, C. Kuo, P. Mugo, J. Kanungi, S. Singh, J. Haberer, F. Priddy and E. J. Sanders (2013). "High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya." AIDS Behav 17(6): 2162-2172.          




van der Elst, E. M., A. D. Smith, E. Gichuru, E. Wahome, H. Musyoki, N. Muraguri, G. Fegan, Z. Duby, L. G. Bekker, B. Bender, S. M. Graham, D. Operario and E. J. Sanders (2013). "Men who have sex with men sensitivity training reduces homoprejudice and increases knowledge among Kenyan healthcare providers in coastal Kenya." J Int AIDS Soc 16 Suppl 3(4 Suppl 3): 18748.       



van Gils, M. J. and R. W. Sanders (2013). "Broadly neutralizing antibodies against HIV-1: templates for a vaccine." Virology 435(1): 46-56.              



Wahome, E., G. Fegan, H. S. Okuku, P. Mugo, M. A. Price, G. Mwashigadi, A. Thiong'o, S. M. Graham and E. J. Sanders (2013). "Evaluation of an empiric risk screening score to identify acute and early HIV-1 infection among MSM in Coastal Kenya." AIDS 27(13): 2163-2166.             



Wall, K. M., B. Vwalika, L. Haddad, N. H. Khu, C. Vwalika, W. Kilembe, E. Chomba, R. Stephenson, D. Kleinbaum, A. Nizam, I. Brill, A. Tichacek and S. Allen (2013). "Impact of long-term contraceptive promotion on incident pregnancy: a randomized controlled trial among HIV-positive couples in Lusaka, Zambia." J Acquir Immune Defic Syndr 63(1): 86-95.    



Yue, L., H. A. Prentice, P. Farmer, W. Song, D. He, S. Lakhi, P. Goepfert, J. Gilmour, S. Allen, J. Tang, R. A. Kaslow and E. Hunter (2013). "Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection." J Virol 87(2): 708-715.             



Zhang, X., O. Wallace, K. J. Wright, M. Backer, J. W. Coleman, R. Koehnke, E. Frenk, A. Domi, M. J. Chiuchiolo, J. DeStefano, S. Narpala, R. Powell, G. Morrow, C. Boggiano, T. J. Zamb, C. Richter King and C. L. Parks (2013). "Membrane-bound SIV envelope trimers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector." Virology 446(1-2): 25-36.      



Zhou, T., J. Zhu, X. Wu, S. Moquin, B. Zhang, P. Acharya, I. S. Georgiev, H. R. Altae-Tran, G. Y. Chuang, M. G. Joyce, Y. Do Kwon, N. S. Longo, M. K. Louder, T. Luongo, K. McKee, C. A. Schramm, J. Skinner, Y. Yang, Z. Yang, Z. Zhang, A. Zheng, M. Bonsignori, B. F. Haynes, J. F. Scheid, M. C. Nussenzweig, M. Simek, D. R. Burton, W. C. Koff, N. C. S. Program, J. C. Mullikin, M. Connors, L. Shapiro, G. J. Nabel, J. R. Mascola and P. D. Kwong (2013). "Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies." Immunity 39(2): 245-258.        



Zhu, J., G. Ofek, Y. Yang, B. Zhang, M. K. Louder, G. Lu, K. McKee, M. Pancera, J. Skinner, Z. Zhang, R. Parks, J. Eudailey, K. E. Lloyd, J. Blinn, S. M. Alam, B. F. Haynes, M. Simek, D. R. Burton, W. C. Koff, N. C. S. Program, J. C. Mullikin, J. R. Mascola, L. Shapiro and P. D. Kwong (2013). "Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains." Proc Natl Acad Sci U S A 110(16): 6470-6475.